Assort Health closed a $120 million Series C led by Menlo Ventures on June 24, 2026, valuing the company at $1.2 billion. The company has now raised more than $222 million in total and has processed over 190 million patient interactions across its platform.

The funding is a clear signal that voice AI in healthcare is no longer a pilot category. It is becoming infrastructure.

What Assort Health Actually Does

Assort Health runs AI agents across the full patient journey — not just scheduling, but intake forms, referrals, document processing, medication refills, real-time eligibility checks, lab requests, and payments. It integrates natively with Epic and Athena, the two dominant electronic health record systems, which means deployment happens inside existing clinical workflows rather than around them.

The performance numbers they published with the round are worth pausing on:

• 5% lift in appointment volume
• 115% increase in labor capacity
• 4.3 out of 5 patient satisfaction score
• 20x revenue growth over the past 15 months

A 115% increase in labor capacity does not mean patients are getting worse care. It means the same clinical staff can handle more than twice the administrative throughput without adding headcount — because the agents are absorbing the calls, confirmations, follow-ups, and paperwork that used to consume staff time.

Why This Round Matters Beyond Healthcare

The healthcare funding story is interesting on its own. But what makes it relevant to any business leader thinking about AI is the operational model Assort Health has demonstrated.

Voice AI agents are most valuable in environments where the interaction volume is high, the work is repetitive, and the consequences of dropping a call are real. Healthcare ticks all three boxes. A missed appointment reminder leads to empty slots and lost revenue. A delayed refill approval creates friction that drives patients to switch providers. A patient who can’t get through during peak hours leaves.

Assort Health’s platform absorbs all of that friction. The 190 million patient interactions processed by the platform is not a vanity metric — it is the training data and operational proof that the agents work at scale.

The same logic applies across industries. Professional services firms lose billable time to intake calls. Real estate agencies lose leads because nobody answered at 7pm. Trades businesses waste truck rolls because pre-visit screening did not happen. The operational problem is identical. The solution architecture is the same: a voice AI agent that handles the high-volume, repeatable front-end work so people can focus on the work that actually requires a human.

The Market Signal

Venture investors poured more than $7 billion into voice AI startups in the first quarter of 2026. The Assort Health round adds to a clear pattern: money is moving toward companies that have moved past demos and into documented operational performance.

Gartner projected that conversational AI deployments would reduce contact center labor costs by $80 billion globally in 2026. The Assort Health metrics give that projection a concrete face. 115% increase in labor capacity across a healthcare organization is not an estimate — it is a measured outcome from a production deployment.

What the market is now rewarding is not the boldest voice AI pitch. It is the most defensible proof of deployment at scale.

What This Means for Business

If you run a business where the phone is part of how you deliver service, the Assort Health round tells you something important: the window where voice AI is a competitive advantage rather than table stakes is narrowing. Healthcare providers that deploy in 2026 will have optimized their patient journey while competitors are still building business cases.

The companies extracting genuine value from voice AI share two traits. They define the specific workflows they want to automate before they start. And they choose systems that integrate into what already exists rather than requiring a platform migration.

The $1.2 billion valuation on a company built entirely around the patient journey shows what focused, integration-first voice AI is worth to the market. The same story is playing out in every vertical where volume, repetition, and after-hours demand create a gap between what human staff can handle and what customers need.

---

The practical next step is the free Working With Claude field guide. Thirty-two pages covering the ecosystem, Claude Code, and how to govern a rollout properly. Get your copy.